Giuseppe Di Grazia received his Master Degree in Medicine and Surgery from the University of Catania in 2020 and his Specialization in Medical Oncology in 2026 from the University of Messina. He worked as a medical resident at Humanitas Istituto Clinico Catanese (2023-2024). In 2025, he moved to Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) as a research fellow. In 2025, he was awarded an ESMO Research Fellowship and he currently works as an ESMO research fellow at FRCB-IDIBAPS, Barcelona.
His research topics mainly include translational oncology, HR+/HER2- breast cancer, targeted therapy, and characterization of resistance mechanisms to standard therapies.
Giuseppe Di Grazia received his Master Degree in Medicine and Surgery from the University of Catania in 2020 and his Specialization in Medical Oncology in 2026 from the University of Messina. He worked as a medical resident at Humanitas Istituto Clinico Catanese (2023-2024). In 2025, he moved to Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) as a research fellow. In 2025, he was awarded an ESMO Research Fellowship and he currently works as an ESMO research fellow at FRCB-IDIBAPS, Barcelona.
His research topics mainly include translational oncology, HR+/HER2- breast cancer, targeted therapy, and characterization of resistance mechanisms to standard therapies.